3. Antiprotozoal and antihelminthic drugs Flashcards
protozoal infection
Malaria Amoebiasis Trypanosomiasis Leishmaniasis toxoplasmosis
Malaria stages
liver form
erythrocytes form
gametocytes
drugs act on liver form
schizonticides
drug - Primaquine
drugs act on erythrocytes form
schizonticides
drugs ... Chloroquine Mefloquine Quinine Artemisinins Pyrimethamine
drugs act on gametocytes
Gametocides
drug - Primaquine
Primaquine
schizonticides
Administration: Oral
Given for: P.vivax and ovale (persistent forms)
act on the liver form
Contraindications: G6PD deficiency (testing is obligatory before usage), pregnancy
Adverse effects: well tolerated, with higher dose: GI, rarely leucopenia, methemoglobinemia, hypersensitivity
Chloroquine
schizonticides
_concentrates in parasites, inhibit DNA transcription and replication, inhibits heme-polymerase
act on the erythrocytes form
DOC in treatment of P. falciparum malaria (not in resistant strains)
Kinetics: good oral absorption, accumulation in the tissue, penetrate the CNS and traverse the placenta
half-life: 5days (loading dose is necessary)
Adverse effects: well tolerated if not too high dose is given
GI symptoms, visual disturbances (cornea and retina deposits), dizziness, headache, pruritus, QT prolongation
Contraindications: psoriasis, porphyry
Mefloquine
schizonticides
act on the erythrocytes form
Pharmacokinetics: good oral absorption | wide distribution | excreted via bile
Clinical use: in MDR forms of P.falciparum, prophylaxis in case of known resistance
Adverse effects: GI and CNS (depression and other psychosis, hallucination, neuropsychiatric reactions), ECG abnormalities
Quinine
schizonticides
MOA: interference with heme polymerisation
Pharmacokinetics: Oral | well distributed
act on the erythrocytes form
Clinical use: Severe infection and chloroquine resistant malaria
Adverse effects: quinism (nausea, vomiting tinnitus and vertigo - reversible), QT prolongation, hemolytic anemia
Potentiates neuromuscular blocking agents and elevation of digoxin levels
Artemisinins
schizonticides
MOA: most likely creating free radical
Not used as monotherapy though there is no resistance so far
Pharmacokinetics: good absorption (p.o.; IV; IM; rectal)
act on the erythrocytes form
Recommended first-line treatment for MDR P.falciparum malaria
Artesunate + sulfadoxine -
pyrimethamine/mefloquine/amodiaquine
Artemether + lumefantrine
Well tolerated – rarely anemia
High dose QT prolongation & HS
Pyrimethamine
schizonticides
act on the erythrocytes form
inhibits dihydrofolate reductase (also affect as a sporontocide - mosquitoes)
In combination with artemisinin derivatives (p.falciparum)
Sulfadiazine + pyrimethamine => against Toxoplasma gondii
first-line treatment for MDR P.falciparum malaria
Artesunate + sulfadoxine -
pyrimethamine/mefloquine/amodiaquine
Artemether + lumefantrine
combination of drugs against Toxoplasma gondii
Sulfadiazine + pyrimethamine
Pyrimethamine + clindamycin
Trimethoprim + sulfamethoxazole
Primaquine
acts on all types of plasmodium gametocytes are destroyed
Amoebiasis location
Tissue & luminal
Trypanosomiasis drugs
Pentamidine Suramin Melarsoprol Eflornithine Nifurtimox
Leishmaniasis location
Visceral & Cutaneous
treatment against Tissue amoebas
Metronidazole
Tinidazol
Dehydroemetine
Chloroquine
treatment against Luminal amoebas
Iodoquinol
Paromomycin
Metronidazole
Produces toxic intermediate metabolites (reduction of N2O group) in anaerobic conditions
Bactericidal (and amebicidal)
Spectrum: Anaerobic bacteria (bacteroides and clostridium) | Protozoa (trichomonas, G.lamblia, amoeba, entameba histolytica)
Distribution: good absorption, wide distribution (CNS and abscesses) vaginal and seminal fluids, saliva, breast milk
Administration: Oral, IV and topical
Metabolism: Hepatic oxidation (CYP450) and glucuronidation
Excretion: Urine
Adverse effects: GI (nausea), metallic taste, alcohol-intolerance (disulfiram-like reaction)